Presenility of granulocytes in Down syndrome individuals

American Journal of Medical Genetics

Volumn 84, Issue 5, 1999, Pages 406-412

  Yasui, Kozo ^a   Shinozaki, Koji ^a   Nakazawa, Takayuki ^a   Agematsu, Kazunaga ^a   Komiyama, Atsushi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Eosinophils; Granulocyte macrophage colony stimulating factor; Inflammation; Interleukin 5; Neutrophils

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 5;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DOWN SYNDROME; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; IMMUNOFLUORESCENCE; MALE; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD95; APOPTOSIS; DOWN SYNDROME; EOSINOPHILS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-5; MALE; MIDDLE AGED; NEUTROPHILS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0032957289     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990611)84:5<406::AID-AJMG4>3.0.CO;2-4     Document Type: Article

References (34)

1. Beasley R, Roche WR, Roberts JA, Holgate ST. 1989. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 139:806-817.
2. Brach MA, deVos S, Gruss HJ, Herrmann F. 1992. Prolongation of survival of human polymorphonuclear neutrophils by Granulocyte-Macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 80:2920-2924.
3. Burgio GR, Ugazio A, Nespoli L, Maccario R. 1983. Down syndrome: A model of immunodeficiency. Birth Defects 19:325-327.
4. Cohen JJ. 1991. Programmed cell death in the immune system. Adv Immunol 50:55-85.
5. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. 1992. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012-2020.
6. Ellis RE, Yuan JY, Horvitz HR. 1991. Mechanisms and functions of cell death. Annu Rev Cell Biol 7:663-698.
7. Forni GL, Rasore-Quartino A, Acuitis MS, Strigini P. 1990. Incidence of bronchial asthma in Down syndrome. J Pediatr 116:487.
8. Hockenbery D, Nunez G, Millman C, Shreiber RD, Korsmeyer SJ. 1990. BC1-2, an inner mitochondrial protein that blocks programmed cell death. Nature 348:334-336.
9. Hu B, Yasui K 1997. Effects of colony-stimulating factors (CSFs) on neutrophil apoptosis: possible roles at inflammation site. Int J Hematol 66:179-188.
10. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243.
11. Iwai K, Miyawaki T, Takizawa T, Konno A, Ohta K, Yachie A, Seki H, Taniguchi N. 1994. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84:1201-1208.
12. Khan AJ, Evans HE, Glass L, Shin YH, Almonte D. 1975. Defective neutrophil chemotaxis in patients with Down syndrome. J Pediatr 87:87-89.
13. Kjelmann N-IM. 1988. Epidemiology and prevention of allergy. Allergy 43[suppl 8]: 39-40.
14. Lagasse E, Weissman IL. 1994. bcl-2 inhibits apoptosis of neutrophils but not their engulfinent by macrophages. J Exp Med 179:1047-1052.
15. Lee A, Whyte MKB, Haslett C. 1993. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 54:283-288.
16. Liles CW, Hebanoff SJ. 1995. Regulation of apoptosis in neutrophils - fas track to death? J Immunol 155:3289-3291.
17. Lockitch G, Puterman M, Godolphin W, Sheps S, Tingle AJ, Quigley G. 1989. Infection and immunity in Down syndrome: A trial of long-term low oral doses of zinc. J Pediatr 114:781-787.
18. Lopez AF, Williamson DJ, Gamble JR, Begley CG, Harlan JM, Klebanoff SJ, Waltersdorph A, Wong G, Clark SC, Vadas MA. 1986. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest 78:1220-1228.
19. Masaki M, Higurashi M, Iijima K, Ishikawa N, Tanaka F, Fujii T, Kuroki Y, Matsui I, Iinuma K, Matsuo N, Takeshita K, Hashimoto S. 1981. Mortality and survival for Down's syndrome in Japan. Am J Hum Genet 33:629-631.
20. Matsumoto K, Schleimer RP, Saito H, Iikura Y, Bochner BS. 1995. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 86:1437-1443.
21. Miller RW. 1971. Neoplasia and Down syndrome. Ann NY Acad Sci 171: 637-644.
22. Murphy M, Hyun W, Hunte B, Levine AD, Epstein LB. 1992. A role for tumor necrosis factor-alpha and interferon-gamma in the regulation of interleukin-4-induced human thymocyte proliferation in vitro: heightened sensitivity in the Down syndrome (trisomy 21) thymus. Pediatr Res 32:269-276.
23. Novo E, Garcia MI, Lavergne J. 1993. Nonspecific immunity in Down syndrome: a study of chemotaxis, phagocytosis, oxidative metabolism, and cell surface marker expression of plolymorphonuclear cells. Am J Med Genet 46:384-391.
24. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li WM, Richards S, Dhein J, Trauth BC, Ponsting H, Krammer PH. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J Biol Chem 267:10709-10715.
25. Peled-Kamar M, Lotem J, Okon E, Sachs L, Groner Y. 1995. Thymic abnormalities and enhanced apoptosis of thymocytes and bone marrow cells in transgenic mice overexpressing Cu/Zn-superoxide dismutase: implications for Down Syndrome. EMBO J 14:4985-4993.
26. Savill J. 1997. Apoptosis in resolution of inflammation. J Leukoc Biol 61: 375-380.
27. Spina CA, Smith D, Korn E, Fahey JL, Grossman HJ. 1981. Altered cellular immune functions in patients with Down's syndrome. Am J Dis Child 135:251-255.
28. Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J. 1994. Antiinflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 343:1006-1008.
29. Tanaka M, Suda T, Takahashi T, Nagata S. 1995. Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J 14:1129-1135.
30. Whyte MKB, Meagher LC, MacDermont J, Haslett C. 1993. Impairment of function in aging neutrophils is associated with apoptosis. J Immunol 150:5124-5134.
31. Wooley KL, Gibson PG, Carty K, Wilson AJ, Twaddell SH, Woolley MJ. 1996. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Reap Crit Care 154:237-243.
32. Yasui K, Hu B, Nakazawa T, Agematsu K, Komiyama A. 1997. Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition. J Clin Invest 100:1677-1684.
33. Yasui K, Komiyama A, Molski TFP, Sha'afi RI. 1994a. Pentoxifylline and CD14 antibody additively inhibit priming of polymorphonuclear leukocytes for enhanced release of superoxide by lipopolysaccharide: possible mechanism of these actions. Infect Immun 62:922-927.
34. Yasui K, Yamazaki M, Miyabayashi M, Tsuno T, Komiyama A. 1994b. Signal transduction pathway in human polymorphonuclear leukocytes for chemotaxis induced by a chemotactic factor: distinct from the pathway for superoxide anion production. J Immunol 152:5922-5929.